Monthly Archives: October 2018

//October

Management changes at EMOTRA

Emotra’s CEO announces that he is stepping down. Emotra’s board of directors has appointed Marketing Manager Daniel Poté as the new CEO. Daniel will assume this new position immediately. Margit Ferm has stated that she wishes to step down as chairperson of the board, but will continue her engagement as a board member. Claes Holmberg [...]

By | October 24th, 2018|INVESTORS|Comments Off on Management changes at EMOTRA

EMOTRA announces that a German psychiatric hospital is introducing EDOR

Yesterday, on October 17, 2018, Emotra hosted a training seminar for doctors and test leaders at a number of clinics that belong to a German psychiatric and psychotherapeutic hospital. This training is the start of a controlled introduction of the test in their clinical practice. The hospital will borrow hardware from us during a defined [...]

By | October 19th, 2018|INVESTORS|Comments Off on EMOTRA announces that a German psychiatric hospital is introducing EDOR

Important developments for Emotra

Emotra has reached an important stage in its development. A few days ago, a scientific article was published based on a compilation of the results of earlier blind studies. It shows that hyporeactivity is a clear and strong marker for suicide risk. Furthermore, the Company was recently invited by one of Great Britain’s leading chains [...]

By | October 1st, 2018|INVESTORS|Comments Off on Important developments for Emotra